Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.49 |
| ▸ | SLC22A1 | O15245 | 3/20 | 0.43 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 3/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 2/20 | 0.34 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tetrabuthylammonium SCHEMBL31550869 | 0.91 | EPHX1 (0.53) | EPHX1SLC22A1SLC22A2ALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL17435894 | 0.90 | EPHX1 (0.42) | EPHX1SLC22A1SLC22A2ALDH1A1TP53 | |
| SCHEMBL302116 | 0.87 | EPHX1 (0.55) | EPHX1SLC22A1SLC22A2ALDH1A1TP53 | |
| SCHEMBL303834 | 0.87 | EPHX1 (0.55) | EPHX1SLC22A1SLC22A2ALDH1A1TP53 | |
| SCHEMBL302081 | 0.87 | EPHX1 (0.55) | EPHX1SLC22A1SLC22A2ALDH1A1TP53 | |
| Tetrabuthylammonium SCHEMBL17435902 | 0.85 | SLC22A1 (0.55) | SLC22A1SLC22A2ALDH1A1TP53CYP3A4 | |
| Tetrylammonium SCHEMBL17435864 | 0.81 | CA1 (0.39) | EPHX1TSHRSMN1; SMN2CA1CA2 | |
| Tetrabuthylammonium SCHEMBL160606 | 0.79 | SLC22A1 (0.52) | EPHX1SLC22A1SLC22A2ALDH1A1TP53 | |
| Dodecane SCHEMBL30193423 | 0.78 | EPHX1 (0.67) | EPHX1HSD17B10FAAHCES1CES2 | |
| Nonane SCHEMBL30193525 | 0.78 | EPHX1 (0.67) | EPHX1HSD17B10FAAHCES1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109803952-B | Sulfamic acid derivatives and process for preparing same | 魁北克电力公司 | 2022-10-04 | — | — | CN | disclosed |
| US-11345657-B2 | Sulfamic acid derivatives and processes for their preparation | HYDRO-QUEBEC (CA) | 2022-05-31 | — | — | US | disclosed |
| US-20200181071-A1 | SULFAMIC ACID DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | HYDRO-QUéBEC (CA) | 2020-06-11 | — | — | US | disclosed |
| US-9950929-B2 | Method for producing disulfonylamine alkali metal salt | NIPPON SODA CO., LTD. (JP) | 2018-04-24 | — | — | US | disclosed |
| EP-2977349-A1 | METHOD FOR PRODUCING DISULFONYLAMINE ALKALI METAL SALT | Nippon Soda Co., Ltd. (JP) | 2016-01-27 | — | — | EP | disclosed |
| US-20160016797-A1 | METHOD FOR PRODUCING DISULFONYLAMINE ALKALI METAL SALT | NIPPON SODA CO., LTD. (JP) | 2016-01-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11345657-B2 | Sulfamic acid derivatives and processes for their preparation | STS, SCLY, MPST | EPHX1 3891/4885SLC22A1 2718/4885SLC22A2 2716/4885 |
| US-20200181071-A1 | SULFAMIC ACID DERIVATIVES AND PROCESSES FOR THEIR PREPARATION | STS, SCLY, MPST | EPHX1 3891/4885SLC22A1 2718/4885SLC22A2 2716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.